Showing results (41-50 of 289) with videos related to

Sort By:
Pageof 29
Gastroenterology|May 6, 2014
Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancerYanxin Luo, Chao-Jen Wong, Andrew M Kaz, et al.
Epigenomes|January 21, 2026
Epigenetic Alterations in Colitis-Associated Colorectal CancerNisha Ganesh, William M Grady, Andrew M Kaz
Methods in Molecular Biology (Clifton, N.J.)|May 3, 2018
DNA Methylation Analysis Using Droplet Digital PCRMing Yu, Tai J Heinzerling, William M Grady
Genes, Chromosomes & Cancer|July 30, 2008
The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancersChunguang Guo, Jerome F Sah, Lydia Beard, et al.
Growth Factors (Chur, Switzerland)|July 25, 2008
TGF-beta has paradoxical and context dependent effects on proliferation and anoikis in human colorectal cancer cell linesNina M Muñoz, Ji Yeon Baek, William M Grady
Gastrointestinal Endoscopy Clinics of North America|November 19, 2025
Emerging Biomarkers for Managing Barrett's EsophagusPakdee Rojanasopondist, Andrew Kaz, Ming Yu, et al.
Current Treatment Options in Gastroenterology|March 11, 2004
Surveillance and Treatment of Periampullary and Duodenal Adenomas in Familial Adenomatous PolyposisJ. Chad Johnson, James A. DiSario, William M. Grady
Biochimica Et Biophysica Acta|April 3, 2009
TGF-beta receptor levels regulate the specificity of signaling pathway activation and biological effects of TGF-betaAndres Rojas, Malla Padidam, Dean Cress, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 2, 2016
Use of NCCN Guidelines, Other Guidelines, and Biomarkers for Colorectal Cancer ScreeningChristina D Williams, William M Grady, Leah L Zullig
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 18, 2007
Is TGFBR1*6A a susceptibility allele for nonsyndromic familial colorectal neoplasia?Denise Daley, Wendi Morgan, Susan Lewis, et al.
Pageof 29